Novocure (Nasdaq:NVCR) shares took a hit today on fourth-quarter results that came in mixed compared to the consensus forecast. Shares of NVCR dipped 4.6% at $78.26 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 8.1%. The Root, Switzerland-based tumor-treating fields developer […]
Oncology
Delcath Systems appoints new board chair
Delcath Systems (Nasdaq:DCTH) announced today that its board of directors voted to appoint John R. Sylvester as its new chair. Sylvester joined Delcath as a director in July 2019. He currently serves as CEO of Curium Pharma’s SPECT and international businesses. Previously, Sylvester served as BTG’s chief commercial officer, leading the company’s interventional oncology and […]
FDA approves HistoSonics IDE trial for sonic beam therapy that treats renal tumors
HistoSonics announced today that it received FDA approval for an investigational device exemption (IDE) trial of its Edison system. Minneapolis-based HistoSonics designed its Edison system to target and destroy targeted primary renal tumors. It achieves this in a non-invasive manner without the need for incisions or needles. Edison uses a novel sonic bean therapy called […]
Exact Sciences launches cancer therapy selection test
Exact Sciences (Nasdaq:EXAS) announced that it launched its OncoExTra cancer therapy selection test in the U.S. OncoExTra is a next-generation sequencing, comprehensive DNA- and RNA-based genomic test. Madison, Wisconsin-based Exact Sciences designed it to provide doctors and patients a complete molecular picture of the patient’s cancer. The test provides reliable and actionable results personalized to […]
Varian wins U.S., European clearance for radiotherapy systems
Siemens Healthineers‘ Varian announced today that it received FDA 510(k) clearance and CE mark for its Halcyon and Ethos systems. Both radiotherapy systems feature Varian’s HyperSight imaging solution. HyperSight enables clinicians to capture high-quality images of patients during their daily radiation treatments. The images help in the daily localization of patient tumors and their uses […]
FDA clears biology-guided radiotherapy from RefleXion
RefleXion Medical announced today that the FDA cleared its Scintix biology-guided radiotherapy treatment for cancer. Hayward, California-based RefleXion designed the Scintix platform for use in treating both early- and late-stage cancers. The company said Scintix is the first and only radiotherapy that allows each cancer’s unique biology to autonomously determine how much radiation to deliver. […]
Accuray stock rises on Street-beating Q2
Accuray (Nasdaq:ARAY) shares rose this morning on second-quarter results that topped the consensus forecast. ARAY shares ticked up 12.1% at $2.75 apiece. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 14.4%. The Sunnyvale, California–based radiation oncology company posted losses of $1.9 million. That amounts to losses […]
iCad announces CFO transition
iCad (Nasdaq:ICAD) announced today that its board of directors approved the appointment of Daniel Shea as interim CFO. Shea takes over as interim CFO, effective immediately. The cancer detection and therapy tech company also launched a search for a full-time CFO. Steve Sarno previously held the interim CFO role. The company said in a news […]
Novocure announces leadership team restructuring
Novocure (Nasdaq:NVCR) today announced organizational changes for its leadership team as it prepares for future growth. The company said the changes became effective Jan. 17. Pritesh Shah, Novocure’s chief commercial officer, transitioned into a new role as chief growth officer. His responsibilities include product and portfolio strategy, brand management, launch framework and market access/intelligence. He […]
Burning Rock wins FDA breakthrough nod for multi-cancer blood test
Burning Rock (Nasdaq:BNR) announced today that the FDA granted breakthrough device designation to its OverC blood test. Irvine, California-based Burning Rock developed OverC as a multi-cancer detection blood test (MCDBT). It designed the test to detect cancer types including esophageal, liver, lung, ovarian and pancreatic cancers. Adults of either sex, aged 50-75 years old, at […]
Fujifilm to acquire Inspirata’s digital pathology business
Fujifilm announced today that it entered into an asset purchase agreement for the global digital pathology business of Inspirata. Upon completing the agreement, Fujifilm absorbs Inspirata’s Dynamyx digital pathology technology. Additionally, it takes on employees and customers of the company. Fujifilm expects to complete the transaction in early 2023. Terms of the agreement have not […]